{"id":"W2054541910","doi":"10.1007/s10549-010-1232-1","title":"The PI3 kinase/mTOR blocker NVP-BEZ235 overrides resistance against irreversible ErbB inhibitors in breast cancer cells","year":2010,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":60,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"PI3K/AKT/mTOR pathway; ErbB; Lapatinib; Protein kinase B; Erlotinib; Cancer research; Gefitinib; Breast cancer; Pharmacology; EGFR inhibitors; Drug resistance; Medicine; Cancer; Phosphorylation; Biology; Signal transduction; Internal medicine; Epidermal growth factor receptor; Trastuzumab; Cell biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001009539,0.0002801335,0.0004453744,0.0002033275,0.0001207052,0.0003301175,0.0001848686,0.0001734793,0.001157451],"category_scores_gemma":[0.0001208197,0.0001046658,0.0002751807,0.000218579,0.0001019469,0.0001201849,0.0001409663,0.0005120587,0.0003628067],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002208364,"about_ca_system_score_gemma":0.0002553648,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009426982,"about_ca_topic_score_gemma":0.001377206,"domain_scores_codex":[0.9998214,0.00002465581,0.00002176102,0.0000266383,0.00006039313,0.00004512564],"domain_scores_gemma":[0.9999512,0.00001246314,0.000009988069,0.00001026121,0.000006540298,0.000009480144],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0003110814,0.0001679421,0.0005795332,0.00007589023,0.0000195527,0.0001150636,0.00002811127,0.0003159109,0.9886916,0.0001810152,0.0003243659,0.00918992],"study_design_scores_gemma":[0.00003959297,0.0008237074,0.004831083,0.000004367781,0.0000311718,0.00046618,0.00003267565,0.00142333,0.9887946,0.00003328832,0.003514595,0.000005537862],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9934061,0.001927995,0.001338725,0.0001047716,0.00004649792,0.0000318623,0.0004561438,0.0001618634,0.002526114],"genre_scores_gemma":[0.9958424,0.0008097059,0.001168358,0.00004832716,0.000009209529,0.00002318789,0.0006240115,0.00001728159,0.001457414],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001157451,"threshold_uncertainty_score":0.003872097,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01660315909393041,"score_gpt":0.3102526844706381,"score_spread":0.2936495253767077,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}